Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Markus Cornberg

Showing results (1-10 of 350) with videos related to

Pageof 35
Sort By:
Gut|January 6, 2026
PEG is back: revisiting the role of pegylated interferon alfa and benchmarking its place in HBV cure strategiesMarkus Cornberg
Deutsche Medizinische Wochenschrift (1946)|March 17, 2016
[One pill for all HCV-genotypes?]Markus Cornberg
Deutsche Medizinische Wochenschrift (1946)|February 7, 2018
Markus Cornberg
Deutsche Medizinische Wochenschrift (1946)|October 10, 2025
[Screening and Prevention of Chronic Viral Hepatitis]Markus Cornberg, Lisa Sandmann
Hepatology (Baltimore, Md.)|June 5, 2024
Early treatment of acute or recently acquired hepatitis C: An important tool on the path to HCV elimination!Markus Cornberg, Heiner Wedemeyer
Alimentary Pharmacology & Therapeutics|July 14, 2020
Editorial: which factors influence HBsAg levels in HBV-infected patients?Markus Cornberg, Dieter Glebe
Deutsche Medizinische Wochenschrift (1946)|May 7, 2015
[Hepatitis C in Germany: an analysis of statutory sickness funds claims data]Jörg Tomeczkowski, Markus Cornberg
Innere Medizin (Heidelberg, Germany)|February 28, 2024
[Diagnosis and treatment of viral hepatitis B and D in 2024]Roni Souleiman, Markus Cornberg
Liver International : Official Journal of the International Association for the Study of the Liver|March 24, 2016
The hepatitis E virus: a likely cause of extrahepatic diseases!Heiner Wedemeyer, Markus Cornberg
Hepatology (Baltimore, Md.)|January 10, 2022
HCC and HBV reactivation-A preventable condition not to be missedLisa Sandmann, Markus Cornberg
Pageof 35

Showing results (1-10 of 350) with videos related to

Sort By:
Pageof 35
Gut|January 6, 2026
PEG is back: revisiting the role of pegylated interferon alfa and benchmarking its place in HBV cure strategiesMarkus Cornberg
Deutsche Medizinische Wochenschrift (1946)|March 17, 2016
[One pill for all HCV-genotypes?]Markus Cornberg
Deutsche Medizinische Wochenschrift (1946)|February 7, 2018
Markus Cornberg
Deutsche Medizinische Wochenschrift (1946)|October 10, 2025
[Screening and Prevention of Chronic Viral Hepatitis]Markus Cornberg, Lisa Sandmann
Hepatology (Baltimore, Md.)|June 5, 2024
Early treatment of acute or recently acquired hepatitis C: An important tool on the path to HCV elimination!Markus Cornberg, Heiner Wedemeyer
Alimentary Pharmacology & Therapeutics|July 14, 2020
Editorial: which factors influence HBsAg levels in HBV-infected patients?Markus Cornberg, Dieter Glebe
Deutsche Medizinische Wochenschrift (1946)|May 7, 2015
[Hepatitis C in Germany: an analysis of statutory sickness funds claims data]Jörg Tomeczkowski, Markus Cornberg
Innere Medizin (Heidelberg, Germany)|February 28, 2024
[Diagnosis and treatment of viral hepatitis B and D in 2024]Roni Souleiman, Markus Cornberg
Liver International : Official Journal of the International Association for the Study of the Liver|March 24, 2016
The hepatitis E virus: a likely cause of extrahepatic diseases!Heiner Wedemeyer, Markus Cornberg
Hepatology (Baltimore, Md.)|January 10, 2022
HCC and HBV reactivation-A preventable condition not to be missedLisa Sandmann, Markus Cornberg
Pageof 35